{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T03:55:09Z","timestamp":1778903709288,"version":"3.51.4"},"reference-count":12,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.contraception.2012.10.038","type":"journal-article","created":{"date-parts":[[2012,12,8]],"date-time":"2012-12-08T07:37:42Z","timestamp":1354952262000},"page":"744-749","source":"Crossref","is-referenced-by-count":8,"title":["Therapeutically equivalent pharmacokinetic profile across three application sites for AG200-15, a novel low-estrogen dose contraceptive patch"],"prefix":"10.1016","volume":"87","author":[{"given":"Frank Z.","family":"Stanczyk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David F.","family":"Archer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arkady","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Foegh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2012.10.038_bb0005","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.contraception.2003.10.006","article-title":"The impact of improved compliance with a weekly contraceptive transdermal system (Ortho Evra) on contraceptive efficacy","volume":"69","author":"Archer","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.10.038_bb0010","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0889-8545(05)70178-9","article-title":"Contraceptive compliance","volume":"27","author":"Dardano","year":"2000","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"Suppl. 2","key":"10.1016\/j.contraception.2012.10.038_bb0015","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/S0015-0282(01)03263-0","article-title":"Assessment of compliance with a weekly contraceptive patch (Ortho Evra\/Evra) among North American women","volume":"77","author":"Archer","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2012.10.038_bb0020","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ejogrb.2005.01.021","article-title":"ORTHO EVRA\/EVRA 003 Study Group. Contraceptive efficacy, compliance and beyond: factors related to satisfaction with once-weekly transdermal compared with oral contraception","volume":"121","author":"Urdl","year":"2005","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.contraception.2012.10.038_bb0025","unstructured":"Ortho Evra\u00ae [package insert]. Raritan, NJ: Ortho-McNeil-Janssen Pharmaceuticals, Inc; 2011."},{"key":"10.1016\/j.contraception.2012.10.038_bb0030","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.contraception.2009.12.016","article-title":"ORTHO EVRA and venous thromboembolism: an update","volume":"81","author":"Jick","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.10.038_bb0035","first-page":"231","article-title":"Pharmacokinetics, tolerability and cycle control of three transdermal contraceptive delivery systems containing different doses of ethinyl estradiol and levonorgestrel","volume":"6","author":"Stanczyk","year":"2011","journal-title":"Horm Mol Biol Clin Invest"},{"key":"10.1016\/j.contraception.2012.10.038_bb0040","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.contraception.2011.10.006","article-title":"Ethinyl estradiol and levonorgestrel pharmacokinetics with a low-dose transdermal contraceptive delivery system, AG200-15: a randomized controlled trial","volume":"85","author":"Archer","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.10.038_bb0045","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1046\/j.0306-5251.2001.01532.x","article-title":"Pharmacokinetics of a contraceptive patch (Evra\/Ortho Evra) containing norelgestromin and ethinyloestradiol at four application sites","volume":"53","author":"Abrams","year":"2002","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.contraception.2012.10.038_bb0050","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jchromb.2006.12.052","article-title":"A semi-automated 96-well plate method for the simultaneous determination of oral contraceptives concentrations in human plasma using ultra performance liquid chromatography coupled with tandem mass spectrometry","volume":"852","author":"Licea-Perez","year":"2007","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.contraception.2012.10.038_bb0055","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.contraception.2005.03.005","article-title":"Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch and an oral contraceptive","volume":"72","author":"van den Heuvel","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2012.10.038_bb0060","unstructured":"Lybrel\u00ae [package insert]. Philadelphia, PA: Wyeth Pharmaceuticals Inc.; 2010."}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782412009705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782412009705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T09:59:22Z","timestamp":1540029562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782412009705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":12,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0010782412009705"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2012.10.038","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}